LD-2 disclosure · 2nd Quarter - Report
STRATIVA PHARMACEUTICALS
Coverage · No income or expenses were reported on this filing.
Client
- Description
- PAR Pharmaceutical's proprietary supportive care therapeutics & select oncology treatments
- Location
- New Jersey · United States of America
Registrant
- Description
- Advocacy & Policy Firm
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
1 issueHealth Issues
Pharmaceutical Manufacturing; Pharmacy Issues; Clinical Pharm-Assist; Medicare Prescription Drug Benefits; American's Health Choices Act (HR 3200), Regulations under MMA re: Medicare Prescription Drug Benefits; Amendments to the Social Security Act Relating To Prescription Drugs. Provisions contained in: HR 3200, America's Affordable Health Choices Act of 2009; America's Healthy Future Act of 2009 (Senate Finance Committee' Baucus Bill Proposal) Affordable Health Choices Act of 2009 (Senate Committee on Health, Education, Labor and Pensions Committee Proposed Legislation; THE HEALTH CARE & EDUCATION RECONCILIATION ACT of 2010 (H.R. 4872) The Patient Protection and Affordable Care Act of 2010 (H.R.3590)
LobbyistsBRAD KILE · LEIGH DAVITIAN
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Centers For Medicare and Medicaid Services (CMS)